Amyloid- β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer's Diseases.

CONCLUSION: Two derivatives have been identified to be biocompatible, non-toxic, neuroprotective against A β -induced toxicities and blood-brain barrier permeable highlighting their promising potential as AD drug candidates for future clinical use. PMID: 31453789 [PubMed - as supplied by publisher]
Source: Current Alzheimer Research - Category: Neurology Authors: Tags: Curr Alzheimer Res Source Type: research